Birch Hill Equity Partners has sold Novadent to Dental Services Group
Lincoln International (“Lincoln”), a leading global mid-market investment bank, is pleased to announce that Birch Hill Equity Partners has sold Novadent, Inc. (“Novadent” or the “Company”) to Dental Services Group, a portfolio company of Cressey & Company LP. Terms of the transaction were not disclosed.
Novadent is a leading full-service dental laboratory with eight networked operating platforms that serve dentists across the U.S. The Company’s dental laboratories provide a full range of custom-made dental appliances, including crown and bridge, dentures, partials, implant restorations, removables, orthodontic appliances and other dental specialties. As a result, Novadent holds a strong market position as one of the largest and most advanced full-service dental laboratory networks of scale in the U.S.
Lincoln acted as the exclusive financial advisor to Birch Hill Equity Partners and Novadent, working closely with the Company’s shareholders and management team throughout the sale process. This included providing advisory expertise and managing the preparatory, marketing, negotiation and due diligence phases of the transaction.
Meet Our Professionals
View More Transactions
Lincoln International has advised Airsweb on its sale to EcoOnline, a Norway-based company backed by Goldman Sachs, Summa Equity and Viking Venture
Lincoln International is pleased to announce that UAS Laboratories LLC, a portfolio company of Lakeview Equity Partners, LLC, has been sold to Chr. Hansen Holding A/S (CPSE:CHR), a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries
Lincoln International is pleased to announce that Sparton Corporation, a portfolio company of Cerberus Capital Management, L.P. (together with its affiliates, “Cerberus”), has sold its manufacturing and design services division (“MDS”) to One Equity Partners
Lincoln International is pleased to announce that it has advised Doppel Farmaceutici, a portfolio company of Trilantic Europe, on the financing of its acquisition of Dietopack